October 19, 2018

Xcenda's PRO Thought Leader Featured in The American Journal of Managed Care

Xcenda's thought leader for patient-reported outcomes, Somali Misra Burgess, PhD, provides insights to a recent article in The American Journal of Managed Care® (AJMC®). The article titled, What's Preventing Widespread Use of Patient-Reported Outcomes in Drug Development? looks at the current challenges facing stakeholders in adopting more PRO measures for coverage decisions. 

What's Preventing Widespread Use of Patient-Reported Outcomes in Drug Development?

Xcenda's thought leader on patient-reported outcomes (PROs), Somali Misra Burgess, PhD, spoke with Jaime Rosenberg from the American Journal of Managed Care® (AJMC®) to provide insights on the variety of challenges facing stakeholder when considering PROs. 

 

Somali Burgess, PhD, senior director, Xcenda

“While there is a push to include PRO measures as end points in phase 3 clinical trials for drug approval, integration has been slow.”

More Company News

News

Xcenda has been named a finalist for the Biosimilar Initiative of the Year in the 2021 Global Generics & Biosimilars Awards

September 2021

News

Xcenda and UMass Chan Medical School’s Commonwealth Medicine collaborate to enhance health care decision makers’ view of pharmaceutical pipeline

September 2021

News

Xcenda’s Fall 2021 MCN Virtual Forum announced for October 2021 

July 2021